Game Creek Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.77M | Sell |
134,375
-500
| -0.4% | -$13.3K | 1.25% | 28 |
|
|
2025
Q4 | $3.36M | Buy |
134,875
+7,375
| +6% | +$186K | 1.11% | 32 |
|
|
2025
Q3 | $3.25M | Sell |
127,500
-40,125
| -24% | -$990K | 1.14% | 29 |
|
|
2025
Q2 | $4.06M | Buy |
167,625
+8,375
| +5% | +$195K | 1.74% | 18 |
|
|
2025
Q1 | $4.04M | Sell |
159,250
-74,125
| -32% | -$1.94M | 2.02% | 14 |
|
|
2024
Q4 | $6.19M | Sell |
233,375
-35,625
| -13% | -$966K | 2.42% | 10 |
|
|
2024
Q3 | $7.78M | Sell |
269,000
-41,625
| -13% | -$1.21M | 3.53% | 5 |
|
|
2024
Q2 | $8.69M | Buy |
310,625
+3,375
| +1% | +$92.9K | 4.45% | 5 |
|
|
2024
Q1 | $8.53M | Buy |
307,250
+143,750
| +88% | +$3.99M | 4.08% | 6 |
|
|
2023
Q4 | $4.71M | Buy |
163,500
+42,750
| +35% | +$1.29M | 1.97% | 13 |
|
|
2023
Q3 | $4.01M | Sell |
120,750
-32,750
| -21% | -$1.16M | 2.48% | 11 |
|
|
2023
Q2 | $5.63M | Buy |
153,500
+12,500
| +9% | +$487K | 3.17% | 10 |
|
|
2023
Q1 | $5.75M | Sell |
141,000
-28,450
| -17% | -$1.23M | 3.23% | 9 |
|
|
2022
Q4 | $8.68M | Sell |
169,450
-18,300
| -10% | -$877K | 4.98% | 3 |
|
|
2022
Q3 | $8.22M | Buy |
187,750
+15,650
| +9% | +$760K | 4.99% | 2 |
|
|
2022
Q2 | $9.02M | Sell |
172,100
-6,600
| -4% | -$336K | 4.79% | 2 |
|
|
2022
Q1 | $9.25M | Sell |
178,700
-93,550
| -34% | -$4.85M | 3.66% | 5 |
|
|
2021
Q4 | $16.1M | Sell |
272,250
-26,500
| -9% | -$1.31M | 6.67% | 2 |
|
|
2021
Q3 | $12.8M | Buy |
298,750
+17,500
| +6% | +$775K | 5.52% | 2 |
|
|
2021
Q2 | $11M | Buy |
281,250
+21,750
| +8% | +$846K | 5.54% | 2 |
|
|
2021
Q1 | $9.4M | Buy |
259,500
+33,500
| +15% | +$1.19M | 5.27% | 2 |
|
|
2020
Q4 | $8.32M | Sell |
226,000
-38,818
| -15% | -$1.42M | 4.9% | 3 |
|
|
2020
Q3 | $9.22M | Buy |
264,818
+4,743
| +2% | +$166K | 6.93% | 1 |
|
|
2020
Q2 | $8.07M | Buy |
260,075
+187,349
| +258% | +$6.36M | 6.61% | 1 |
|
|
2020
Q1 | $2.25M | Buy |
72,726
+24,505
| +51% | +$835K | 2.09% | 23 |
|
|
2019
Q4 | $1.79M | Sell |
48,221
-9,749
| -17% | -$347K | 1.01% | 33 |
|
|
2019
Q3 | $1.98M | Buy |
57,970
+1,844
| +3% | +$67.1K | 0.95% | 36 |
|
|
2019
Q2 | $2.31M | Sell |
56,126
-23,451
| -29% | -$931K | 1.33% | 31 |
|
|
2019
Q1 | $3.21M | Hold |
79,577
| – | – | 1.56% | 27 |
|
|
2018
Q4 | $3.3M | Sell |
79,577
-10,804
| -12% | -$448K | 1.55% | 29 |
|
|
2018
Q3 | $3.78M | Sell |
90,381
-30,829
| -25% | -$1.19M | 1.39% | 29 |
|
|
2018
Q2 | $4.17M | Sell |
121,210
-36,890
| -23% | -$1.26M | 1.77% | 26 |
|
|
2018
Q1 | $5.32M | Buy |
158,100
+147,349
| +1,371% | +$5.07M | 2.33% | 15 |
|
|
2017
Q4 | $369K | Buy |
+10,751
| New | +$367K | 0.1% | 153 |
|
Other funds holding PFE
VCM
VPM
Game Creek Capital's PFE Position: Q1 2026 in Review
Game Creek Capital reduced its Pfizer (PFE) stake by 0.37% in Q1 2026, selling an estimated $13.3K and leaving 134,375 shares worth $3.77M. The position accounts for 1.25% of the portfolio, ranked #28.
Game Creek Capital first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $16.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Game Creek Capital held 134,375 shares of Pfizer worth $3.77M as of Q1 2026.
- Game Creek Capital sold 500 Pfizer shares in Q1 2026, an estimated $13.3K.
- Pfizer made up 1.25% of Game Creek Capital's portfolio in Q1 2026, its #28 holding.
- Game Creek Capital first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- Game Creek Capital's Pfizer position peaked at $16.1M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.